2017-2021 UK Hemostasis Analyzers and Consumables: Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
![](/report_cover/2215/2017-2021-uk-hemostasis-analyzers-n-consumables_en.gif)
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market during the next five years.
The report explores business and technological trends in the UK coagulation testing market; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Coagulation Tests
Activated Clotting Time (ACT) (1), Activated Protein C Resistance,
Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,
D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX,
Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,
Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,
Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,
Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,
Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,
Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
- Sales and market shares of major
instrument and reagent suppliers.
Competitive Assessments
- Extensive strategic profiles of
major suppliers and emerging market entrants.
Market Segmentation Analysis
- Comprehensive market
segmentation analysis, including:
- Hospitals
- Commercial/Private Laboratories
- Test volume forecasts for over 40 major procedures
by market segment.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated
analyzers from Diagnostica Stago, Helena, IL,
Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies
and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion
opportunities with significant market appeal.
- “Ideal” product models with tentative
prices and operating characteristics.
- Alternative market penetration
strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
Contains 409 pages and 35 tables
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Routine and Special Coagulation Tests
1. INTRODUCTION
2. ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
3. ALPHA2 ANTIPLASMIN
4. ANTITHROMBIN III
5. BLEEDING TIME
6. DDIMER
7. ETHANOL FLOCCULATION TEST
8. EUGLOBULIN LYSIS
9. FACTOR ASSAYS
a. INTRODUCTION
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. FIBRIN DEGRADATION PRODUCTS
11. FIBRINOGEN
12. HEPARIN
13. HIRUDIN
14. HYPERCOAGULABILITY AND THROMBOSIS
15. LIPOPROTEIN A
16. PLASMIN
17. PLASMINOGEN
18. PLASMINOGEN ACTIVATOR INHIBITOR (PAI)
19. PLATELET FUNCTION TESTS
20. PLATELET AGGREGATION
21. PROTEINS C AND S
22. PROTHROMBIN FRAGMENT 1.2
23. PROTHROMBIN TIME (PT)
24. REPTILASE TIME
25. THROMBIN TIME
26. TISSUETYPE PLASMINOGEN ACTIVATOR (TPA)
27. VON WILLEBRAND'S FACTOR
B. Instrumentation Review
C. Major in Vitro Diagnostic Technologies and Their
Potential Applications
1. CHROMOGENIC SUBSTRATES
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
4. MOLECULAR DIAGNOSTICS
5. MICROCOMPUTERS
6. AUTOMATION
7. ROBOTICS
8. ARTIFICIAL INTELLIGENCE
9. DRY CHEMISTRY
10. BIOSENSORS
III. Spain
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Instrument and Reagent Suppliers’ Sales and Market Shares
X. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
XI. Design Criteria For Decentralized Testing Products
XII. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized TESTING MARKETS
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
XIII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XIV. COMPETITIVE ASSESSMENTS
Abbott
ADI/American Diagnostica
Alere/Biosite/Inverness
AxisShield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data Corporation
ChronoLog
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere
Major Companies Developing or Marketing Activated Clotting Time Tests
Major Companies Developing or Marketing APTT Tests
Major Companies Developing or Marketing Alpha2 Antiplasmin Tests
Major Companies Developing or Marketing Antithrombin III Tests
Major Companies Developing or Marketing Bleeding Time Tests
Major Companies Developing or Marketing Ddimer Tests
Major Companies Developing or Marketing Factor Assays
Major Companies Developing or Marketing Fibrin Degradation
Product Tests
Major Companies Developing or Marketing Fibrinogen Tests
Major Companies Developing or Marketing Heparin Tests
Major Companies Developing or Marketing Plasmin Tests
Major Companies Developing or Marketing Plasminogen Tests
Major Companies Developing or Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing Platelet Aggregation
Tests
Major Companies Developing or Marketing Protein C Tests
Major Companies Developing or Marketing Protein S Tests
Major Companies Developing or Marketing PT Tests
Major Companies Developing or Marketing Thrombin Time Tests
Major Companies Developing or Marketing TPA Tests
Major Companies Developing or Marketing Von Willebrand's
Factor Tests
Executive Summary Table: Spain, Total Coagulation Diagnostics
Market By Market Segment and Product Category
Spain, Laboratories Performing Coagulation Tests By Market Segment
Spain, Hospital Laboratories Performing Coagulation Tests By Bed Size
Spain, Commercial/Private Laboratories Performing Coagulation
Tests By Annual Test Volume Spain, Hospital Laboratories Average Daily Test Volume Spain, Ambulatory Care Centers Average Daily Test Volume Spain, Commercial/Private Laboratories Average Daily Test Volume Spain, Total Coagulation Test Volume By Market Segment
Spain, All Market Segments Coagulation Test Volume
Spain, Hospital Laboratories Coagulation Test Volume
Spain, Ambulatory Care Centers Coagulation Test Volume
Spain, Commercial/Private Laboratories Coagulation Test Volume Spain, Coagulation Reagent Market By Market Segment
Spain, Major Suppliers of Coagulation Reagents, Estimated
Sales and Market Shares Spain, Coagulation Instrument Market By Market Segment
Spain, Major Suppliers of Coagulation Analyzers, Estimated
Instrument Sales and Market Shares Spain, Total Coagulation Diagnostics Market By Product Category
Spain, Major Suppliers of Coagulation Diagnostic Products, Estimates Sales and Market Shares